Spring Health was founded in 2016 by April Koh and Adam Chekroud. In 2021, Koh told Forbes that she would like to take the company public via IPO. As of June 2023, the company remains private.

Spring Health is a digital mental health platform that uses AI to match patients with providers. In 2022 the company acquired Weldon, a family-focused wellness platform. Spring Health has raised more than more than $370 million in venture capital funding from investors including Kinnevik, Tiger Global, GingerBread Capital, Operator Partners, Northzone, Rethink Impact, Work-Bench, SemperVirens, Able Partners, and True Capital. The company was valued at $2.5 billion following a $71 million fundraising round in April 2023.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Register for Details

For more details on financing and valuation for Spring Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Spring Health

To invest in Spring Health pre-IPO

Can you invest in Spring Health pre-IPO?

Spring Health is a privately held company and is not publicly traded, therefore investing in Spring Health pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can learn more about Forge’s Secondary Marketplace and how to invest in private companies before their potential IPO. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

Can you sell shares of Spring Health before it goes public?

You can seek to sell your shares in Spring Health while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is the pre-IPO value of my Spring Health shares?

To determine the value of your Spring Health shares, create a free account to gain access to Forge’s platform. In addition to the Forge Price, Forge Markets contains pricing information for hundreds of pre-IPO companies such as Last Closed Trade Price. A Private Market Specialist will also be available to assist you with any inquiries related to your Spring Health shares. You can also learn more about how to sell your private shares before getting started.

Is Spring Health a publicly traded company?

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

To learn more about Spring Health potential IPO

Will Spring Health go IPO?

Spring Health has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Spring Health’s IPO price?

The Spring Health IPO price does not exist at this time, as Spring Health is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Spring Health register for Forge Markets, today.

When was Spring Health founded?

Spring Health was founded in 2016.

What is Spring Health funding to date?

Spring Health has raised $350.08MM to date.

Who are Spring Health’s major investors?

Bbg Ventures
Gingerbread Capital
Saddlefire Ventures
Innovatehealth Yale
General Catalyst Partners
Sempervirens Venture Capital
Northzone
Generation Investment Management
Business Insider
True Capital
Rethink Impact
Kyle Lowry
True Capital Management
Crew Capital
Mongodb Ventures
Rough Draft Ventures
Rethink Capital Partners
American Psychiatric Association
Guardian Life
William K Warren Foundation
Equinox Ventures
Operator Partners
Able Partners
Rre
Masschallenge
Undisclosed Investors
New York Digital Health Innovation Lab
Alleycorp
Nomad Health
Equiam
Northzone Ventures
Work-Bench
William K. Warren Foundation
Kinnevik
Rre Ventures
Tiger Global
The Partnership Fund For New York City
The Guardian Life Insurance Company Of America
Kerdos Ventures
Sempervirens
True Capital Ventures
North Sound Ventures
Yale Entrepreneurial Institute
The William K. Warren Foundation
Kevin Ryan
Breanna Stewart
Tiger Global Management

Spring Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
07/31/2024 Series E $100MM $xx.xx $3.3B Generation Investment Management, Kinnevik, William K Warren Foundation, RRE, Northzone
Price per Share
$xx.xx
Shares Outstanding
1,473,477
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Generation Investment Management, Kinnevik, William K Warren Foundation, RRE, Northzone
04/12/2023 Series D $70MM $xx.xx $2.5B Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
1,276,066
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
09/16/2021 Series C $150MM $xx.xx $1.99B Kinnevik, Guardian Life, Tiger Global, Northzone, RRE Ventures, Rethink Impact, Work-Bench, William K Warren Foundation, SemperVirens, Able Partners, True Capital Ventures
Price per Share
$xx.xx
Shares Outstanding
3,267,653
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Kinnevik, Guardian Life, Tiger Global, Northzone, RRE Ventures, Rethink Impact, Work-Bench, William K Warren Foundation, SemperVirens, Able Partners, True Capital Ventures
11/20/2020 Series A-2 $20.25MM $xx.xx $85.84MM Northzone, Equinox Ventures, Able Partners, Rethink Impact, Work-Bench, RRE, Sempervirens, William K. Warren Foundation
Price per Share
$xx.xx
Shares Outstanding
7,068,697
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Northzone, Equinox Ventures, Able Partners, Rethink Impact, Work-Bench, RRE, Sempervirens, William K. Warren Foundation
01/27/2020 Series A-1 $1.5MM $xx.xx $29.96MM GingerBread Capital, Operator Partners, Northzone, Rethink Impact, William K. Warren Foundation, Work-Bench, SemperVirens, Able Partners, True Capital, Kyle Lowry, Breanna Stewart
Price per Share
$xx.xx
Shares Outstanding
1,047,215
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
GingerBread Capital, Operator Partners, Northzone, Rethink Impact, William K. Warren Foundation, Work-Bench, SemperVirens, Able Partners, True Capital, Kyle Lowry, Breanna Stewart
07/12/2018 Series Seed-4 $6.22MM $xx.xx $27.29MM Rethink Impact, Work-Bench, BBG Ventures, The Partnership Fund for New York City, RRE Ventures, William K. Warren Foundation
Price per Share
$xx.xx
Shares Outstanding
5,447,058
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Rethink Impact, Work-Bench, BBG Ventures, The Partnership Fund for New York City, RRE Ventures, William K. Warren Foundation
04/10/2017 Series Seed-3 $419,527 $xx.xx $8.43MM William K. Warren Foundation, Kevin Ryan, Business Insider, Nomad Health, MongoDB., RRE Ventures, North Sound Ventures, Saddlefire Ventures, Rough Draft Ventures, General Catalyst Partners
Price per Share
$xx.xx
Shares Outstanding
483,940
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
William K. Warren Foundation, Kevin Ryan, Business Insider, Nomad Health, MongoDB., RRE Ventures, North Sound Ventures, Saddlefire Ventures, Rough Draft Ventures, General Catalyst Partners
04/10/2017 Series Seed-2 $24,999 $xx.xx $8.43MM William K. Warren Foundation, Kevin Ryan, Business Insider, Nomad Health, MongoDB., RRE Ventures, North Sound Ventures, Saddlefire Ventures, Rough Draft Ventures, General Catalyst Partners
Price per Share
$xx.xx
Shares Outstanding
32,043
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
William K. Warren Foundation, Kevin Ryan, Business Insider, Nomad Health, MongoDB., RRE Ventures, North Sound Ventures, Saddlefire Ventures, Rough Draft Ventures, General Catalyst Partners
04/10/2017 Series Seed-1 $1.66MM $xx.xx $8.43MM William K. Warren Foundation, Kevin Ryan, Business Insider, Nomad Health, MongoDB., RRE Ventures, North Sound Ventures, Saddlefire Ventures, Rough Draft Ventures, General Catalyst Partners
Price per Share
$xx.xx
Shares Outstanding
2,400,805
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
William K. Warren Foundation, Kevin Ryan, Business Insider, Nomad Health, MongoDB., RRE Ventures, North Sound Ventures, Saddlefire Ventures, Rough Draft Ventures, General Catalyst Partners
Updated on: Nov 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.